- Home
- ADPT vs ABM Comparison
ADPT vs ABM Comparison
Compare ADPT & ABM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADPT
- ABM
- Stock Information
- Founded
- ADPT 2009
- ABM 1909
- Country
- ADPT United States
- ABM United States
- Employees
- ADPT N/A
- ABM N/A
- Industry
- ADPT Biotechnology: Biological Products (No Diagnostic Substances)
- ABM Diversified Commercial Services
- Sector
- ADPT Health Care
- ABM Finance
- Exchange
- ADPT Nasdaq
- ABM Nasdaq
- Market Cap
- ADPT 2.6B
- ABM 2.8B
- IPO Year
- ADPT 2019
- ABM N/A
- Fundamental
- Price
- ADPT $20.36
- ABM $43.13
- Analyst Decision
- ADPT Strong Buy
- ABM Strong Buy
- Analyst Count
- ADPT 10
- ABM 3
- Target Price
- ADPT $16.60
- ABM $55.67
- AVG Volume (30 Days)
- ADPT 2.4M
- ABM 508.0K
- Earning Date
- ADPT 11-05-2025
- ABM 12-17-2025
- Dividend Yield
- ADPT N/A
- ABM 2.46%
- EPS Growth
- ADPT N/A
- ABM N/A
- EPS
- ADPT N/A
- ABM 1.84
- Revenue
- ADPT $252,754,000.00
- ABM $8,627,900,000.00
- Revenue This Year
- ADPT $36.43
- ABM $5.43
- Revenue Next Year
- ADPT $12.31
- ABM $3.15
- P/E Ratio
- ADPT N/A
- ABM $23.34
- Revenue Growth
- ADPT 42.57
- ABM 4.27
- 52 Week Low
- ADPT $4.76
- ABM $40.00
- 52 Week High
- ADPT $20.76
- ABM $58.18
- Technical
- Relative Strength Index (RSI)
- ADPT 73.37
- ABM 51.46
- Support Level
- ADPT $13.28
- ABM $41.56
- Resistance Level
- ADPT $14.24
- ABM $42.74
- Average True Range (ATR)
- ADPT 1.19
- ABM 0.99
- MACD
- ADPT 0.57
- ABM 0.20
- Stochastic Oscillator
- ADPT 95.19
- ABM 83.96
About ADPT Adaptive Biotechnologies Corporation
Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers, including diffuse large B-cell lymphoma (DLBCL).
About ABM ABM Industries Incorporated
ABM Industries Inc is a provider of integrated facility solutions. It offers its solutions through five segments: Business and Industry, Manufacturing and Distribution, Education, Aviation and Technical solutions. The company derives the majority of its revenue from the business and industry segment, which encompasses janitorial, facilities engineering, and parking services for commercial real estate properties and sports and entertainment venues, hospitals, as well as vehicle maintenance and other services to rental car providers. The company mainly operates in the United States of America.